Cytokeratin 20 mRNA in Blood of Colorectal Cancer Patients
Author Information
Author(s): NO Funaki, J Tanaka, G Ohshio, H Onodera, S Maetani, M Imamura
Primary Institution: Shiga Medical Center for Adult Diseases
Hypothesis
Can the presence of CK20 mRNA in peripheral blood indicate the risk of recurrence in colorectal carcinoma patients?
Conclusion
The presence of CK20 mRNA in blood may serve as a useful indicator for identifying colorectal carcinoma patients at high risk of recurrence.
Supporting Evidence
- All patients with recurrence were positive for CK20 mRNA.
- Four patients in Dukes' C stage with metastasis were also positive.
- Five of nine patients in Dukes' C stage without metastasis were positive, with three developing recurrence.
- None of the healthy controls or patients with non-cancerous diseases tested positive for CK20 mRNA.
Takeaway
Doctors can check for a special marker in the blood of colorectal cancer patients to see if they might get sick again.
Methodology
The study used a highly sensitive reverse transcription and nested PCR method to detect CK20 mRNA in blood samples from patients.
Potential Biases
Possible contamination by normal epithelial cells could affect results.
Limitations
The follow-up period was limited, and the study primarily focused on advanced stages of cancer.
Participant Demographics
Included 28 colorectal carcinoma patients, 5 patients with non-cancerous intestinal diseases, and 6 healthy controls.
Want to read the original?
Access the complete publication on the publisher's website